AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$162.70
−1.26%Margins
Gross margin
81.9%
EBITDA margin
33.7%
EBIT margin
22.8%
Net margin
17.0%
FCF margin
14.2%
20.8%
Return on equity
9.0%
Return on assets
16.9%
Return on invested capital
0.53x
Asset turnover
$13.8B
Cash from operations
$3.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026